AF
GILD icon

Arrow Financial’s Gilead Sciences GILD Stock Holding History

Arrow Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-619
Closed -$51.9K – 226
2024
Q3 		$51.9K Sell
619
-539
-47% -$41.1K ﹤0.01% 216
2024
Q2 		$79.5K Hold
1,158
– – 0.01% 191
2024
Q1 		$84.8K Sell
1,158
-1
-0.1% -$77 0.01% 188
2023
Q4 		$93.9K Sell
1,159
-200
-15% -$15.6K 0.01% 183
2023
Q3 		$102K Hold
1,359
– – 0.01% 181
2023
Q2 		$105K Sell
1,359
-365
-21% -$29.1K 0.01% 175
2023
Q1 		$143K Hold
1,724
– – 0.02% 164
2022
Q4 		$148K Sell
1,724
-830
-32% -$65.7K 0.02% 162
2022
Q3 		$157K Hold
2,554
– – 0.02% 158
2022
Q2 		$157K Sell
2,554
-865
-25% -$53.6K 0.02% 164
2022
Q1 		$204K Sell
3,419
-1,472
-30% -$94.1K 0.02% 160
2021
Q4 		$354K Sell
4,891
-8,112
-62% -$559K 0.04% 144
2021
Q3 		$909K Sell
13,003
-37
-0.3% -$2.6K 0.12% 106
2021
Q2 		$898K Buy
13,040
+254
+2% +$17K 0.11% 112
2021
Q1 		$827K Buy
12,786
+649
+5% +$41.8K 0.11% 115
2020
Q4 		$707K Buy
12,137
+1,028
+9% +$62K 0.14% 110
2020
Q3 		$702K Sell
11,109
-758
-6% -$52.6K 0.15% 108
2020
Q2 		$913K Sell
11,867
-178
-1% -$13.6K 0.2% 93
2020
Q1 		$901K Buy
12,045
+164
+1% +$11.3K 0.21% 85
2019
Q4 		$771K Buy
11,881
+2,025
+21% +$132K 0.15% 102
2019
Q3 		$625K Buy
9,856
+1,360
+16% +$88.9K 0.13% 112
2019
Q2 		$574K Buy
8,496
+547
+7% +$36K 0.12% 117
2019
Q1 		$517K Buy
7,949
+210
+3% +$14K 0.12% 127
2018
Q4 		$483K Sell
7,739
-140
-2% -$9.79K 0.12% 121
2018
Q3 		$609K Buy
7,879
+90
+1% +$6.8K 0.13% 124
2018
Q2 		$551K Sell
7,789
-2,623
-25% -$185K 0.12% 121
2018
Q1 		$786K Buy
10,412
+686
+7% +$54.5K 0.18% 104
2017
Q4 		$697K Buy
9,726
+525
+6% +$39.9K 0.16% 110
2017
Q3 		$746K Sell
9,201
-8,570
-48% -$655K 0.18% 107
2017
Q2 		$1.26M Buy
17,771
+45
+0.3% +$2.99K 0.3% 84
2017
Q1 		$1.2M Sell
17,726
-10,438
-37% -$734K 0.29% 87
2016
Q4 		$2.02M Sell
28,164
-1,826
-6% -$136K 0.5% 60
2016
Q3 		$2.37M Sell
29,990
-10,928
-27% -$888K 0.6% 52
2016
Q2 		$3.41M Sell
40,918
-1,397
-3% -$124K 0.89% 31
2016
Q1 		$3.89M Sell
42,315
-5,500
-12% -$496K 1.03% 28
2015
Q4 		$4.84M Buy
47,815
+5,119
+12% +$533K 1.29% 21
2015
Q3 		$4.19M Buy
42,696
+1,503
+4% +$167K 1.19% 22
2015
Q2 		$4.82M Buy
41,193
+2,550
+7% +$279K 1.31% 21
2015
Q1 		$3.79M Buy
38,643
+1,083
+3% +$110K 1.02% 28
2014
Q4 		$3.54M Buy
37,560
+4,750
+14% +$491K 0.97% 31
2014
Q3 		$3.49M Buy
32,810
+3,790
+13% +$371K 0.97% 24
2014
Q2 		$2.4M Sell
29,020
-9,680
-25% -$753K 0.65% 48
2014
Q1 		$2.74M Sell
38,700
-13,700
-26% -$1.07M 0.78% 38
2013
Q4 		$3.94M Buy
52,400
+6,080
+13% +$423K 1.13% 19
2013
Q3 		$2.91M Buy
46,320
+2,245
+5% +$134K 0.89% 31
2013
Q2 		$2.26M Buy
+44,075
New +$2.3M 0.72% 41

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrow Financial's GILD Position: Q4 2024 in Review

Arrow Financial sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 619 shares — an estimated $51.9K sold.

Arrow Financial first reported a position in GILD in Q2 2013 and held it in 46 quarters. The position peaked at $4.84M in Q4 2015. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Arrow Financial reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Arrow Financial sold 619 Gilead Sciences shares in Q4 2024, an estimated $51.9K.
  • Arrow Financial first reported a position in Gilead Sciences in Q2 2013 and held it in 46 quarters.
  • Arrow Financial's Gilead Sciences position peaked at $4.84M in Q4 2015.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.